Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $21.29B | Exchange | SAU |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | SA | CEO | Faisal Bin Abdullah Ali Al Nassar |
| IPO Date | 2020-03-17 | CAGR | 10.34% |
| Employees | 10,475 | Website | www.hmg.com |
| Div. Yield | 8.9% | Payout Ratio | 68% |
| Buy Back Yield | — | Total Yield | 8.9% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $20.74B | P/E | 34.13 | Forward P/E | 26.15 | PEG | 2.74 |
| P/S | 1.3 | P/B | 2.31 | P/CF | 5.08 | P/FCF | 13.28 |
| Sales | $3.88B | Sales 1Y | 15.49% | Sales 3Y | 64.4% | Sales 5Y | 116.04% |
| EPS | $1.78 | EPS 1Y | 2.67% | EPS 3Y | 31.62% | EPS 5Y | 91.94% |
| Sales QoQ | 16.61% | EPS QoQ | 31.25% | Sales QoQ Avg | 4.66% | EPS QoQ Avg | 4.65% |
| Gross Margin | 29.37% | Operating Margin | 18.67% | Profit Margin | 16.56% | ROCE | 14.23% |
| ROA | 10% | ROE | 30% | Altman Z Score | 4.34 | Piotroski Score | 5 |
| Current Ratio | 1.12 | Quick Ratio | 0.9 | Cash Ratio | 0.42 | Op. CF Ratio | 0.14 |
| Debt/Equity | 1.17 | Debt/Assets | 0.39 | Lt Debt/Equity | 1.12 | Lt Debt/Cap. | 0.52 |
| Intrst Cov. | 7.08 | Inventory Turnover | 8.36 | Asset Turnover | 0.59 | Receivables Turnover | 7.54 |
| Enterprise Value | $20.74B | P/E Ratio | 34.13 |
| Forward P/E | 26.15 | PEG Ratio | 2.74 |
| P/S Ratio | 1.3 | P/B Ratio | 2.31 |
| P/CF Ratio | 5.08 | P/FCF Ratio | 13.28 |
| EPS | $1.78 | EPS Growth 1Y | 2.67% |
| EPS Growth 3Y | 31.62% | EPS Growth 5Y | 91.94% |
| Revenue Growth 1Y | 15.49% | Gross Margin | 29.37% |
| Operating Margin | 18.67% | Profit Margin | 16.56% |
| ROE | 30% | ROA | 10% |
| ROCE | 14.23% | Current Ratio | 1.12 |
| Quick Ratio | 0.9 | Cash Ratio | 0.42 |
| Debt/Equity | 1.17 | Interest Coverage | 7.08 |
| Altman Z Score | 4.34 | Piotroski Score | 5 |
View Dr. Sulaiman Al Habib Medical Services Group Company financial charts →
Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) valuation & financials
Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) has a market capitalization of $21.29B and trades at a price-to-earnings ratio of 34.1. It operates in the Healthcare sector (Medical - Care Facilities).
Dr. Sulaiman Al Habib Medical Services Group Company's revenue grew +15.5% over the last year.
Dr. Sulaiman Al Habib Medical Services Group Company's next earnings report is scheduled for October 21, 2026 (provider scheduled date); analysts estimate EPS of $0.51. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)
Dr. Sulaiman Al Habib Medical Services Group Company revenue & earnings charts →